Literature DB >> 26022625

Genome editing of the germline: broadening the discussion.

Matthew H Porteus1, Christina T Dann2.   

Abstract

Genome editing that results in humans with precisely modified germ cells may never become practical. Nonetheless, the implications are great enough that we strongly support the idea of starting the conversation now, providing time for a broad consensus to be developed. We are confident that if diverse voices are heard, a consensus can be reached on a strategy in which societal mores are respected, the desires of parents are integrated, and the health of future generations is maximized.

Entities:  

Year:  2015        PMID: 26022625      PMCID: PMC4817755          DOI: 10.1038/mt.2015.83

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  14 in total

1.  Chimeric nucleases stimulate gene targeting in human cells.

Authors:  Matthew H Porteus; David Baltimore
Journal:  Science       Date:  2003-05-02       Impact factor: 47.728

2.  Gene therapy fulfilling its promise.

Authors:  Donald B Kohn; Fabio Candotti
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

3.  Don't edit the human germ line.

Authors:  Edward Lanphier; Fyodor Urnov; Sarah Ehlen Haecker; Michael Werner; Joanna Smolenski
Journal:  Nature       Date:  2015-03-26       Impact factor: 49.962

4.  Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA.

Authors:  Chengzu Long; John R McAnally; John M Shelton; Alex A Mireault; Rhonda Bassel-Duby; Eric N Olson
Journal:  Science       Date:  2014-08-14       Impact factor: 47.728

5.  Human gene targeting by viral vectors.

Authors:  D W Russell; R K Hirata
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

6.  Knockout rats via embryo microinjection of zinc-finger nucleases.

Authors:  Aron M Geurts; Gregory J Cost; Yevgeniy Freyvert; Bryan Zeitler; Jeffrey C Miller; Vivian M Choi; Shirin S Jenkins; Adam Wood; Xiaoxia Cui; Xiangdong Meng; Anna Vincent; Stephen Lam; Mieczyslaw Michalkiewicz; Rebecca Schilling; Jamie Foeckler; Shawn Kalloway; Hartmut Weiler; Séverine Ménoret; Ignacio Anegon; Gregory D Davis; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Howard J Jacob; Roland Buelow
Journal:  Science       Date:  2009-07-24       Impact factor: 47.728

7.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

8.  Biotechnology. A prudent path forward for genomic engineering and germline gene modification.

Authors:  David Baltimore; Paul Berg; Michael Botchan; Dana Carroll; R Alta Charo; George Church; Jacob E Corn; George Q Daley; Jennifer A Doudna; Marsha Fenner; Henry T Greely; Martin Jinek; G Steven Martin; Edward Penhoet; Jennifer Puck; Samuel H Sternberg; Jonathan S Weissman; Keith R Yamamoto
Journal:  Science       Date:  2015-03-19       Impact factor: 47.728

9.  Genome editing in mouse spermatogonial stem/progenitor cells using engineered nucleases.

Authors:  Danielle A Fanslow; Stacey E Wirt; Jenny C Barker; Jon P Connelly; Matthew H Porteus; Christina Tenenhaus Dann
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

10.  Rate of de novo mutations and the importance of father's age to disease risk.

Authors:  Augustine Kong; Michael L Frigge; Gisli Masson; Soren Besenbacher; Patrick Sulem; Gisli Magnusson; Sigurjon A Gudjonsson; Asgeir Sigurdsson; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Wendy S W Wong; Gunnar Sigurdsson; G Bragi Walters; Stacy Steinberg; Hannes Helgason; Gudmar Thorleifsson; Daniel F Gudbjartsson; Agnar Helgason; Olafur Th Magnusson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  9 in total

1.  Molecular Therapy Special Issue on Gene Editing Technologies and Applications.

Authors:  Robert Frederickson; Seppo Ylä-Herttuala
Journal:  Mol Ther       Date:  2015-08       Impact factor: 11.454

2.  Gene Editing and Germ-line Intervention: The Need for Novel Responses to Novel Technologies.

Authors:  Courtney Addison; Samuel Taylor-Alexander
Journal:  Mol Ther       Date:  2015-11       Impact factor: 11.454

3.  Islamic Perspectives on CRISPR/Cas9-Mediated Human Germline Gene Editing: A Preliminary Discussion.

Authors:  Noor Munirah Isa; Nurul Atiqah Zulkifli; Saadan Man
Journal:  Sci Eng Ethics       Date:  2019-03-04       Impact factor: 3.525

Review 4.  Is Malaysia Ready for Human Gene Editing: A Regulatory, Biosafety and Biosecurity Perspective.

Authors:  V Kalidasan; Kumitaa Theva Das
Journal:  Front Bioeng Biotechnol       Date:  2021-03-11

Review 5.  Experimental methods to preserve male fertility and treat male factor infertility.

Authors:  Kathrin Gassei; Kyle E Orwig
Journal:  Fertil Steril       Date:  2015-12-30       Impact factor: 7.329

6.  Reasons for being in favour of or against genome modification: a survey of the Dutch general public.

Authors:  S Hendriks; N A A Giesbertz; A L Bredenoord; S Repping
Journal:  Hum Reprod Open       Date:  2018-05-16

Review 7.  Towards a new era in medicine: therapeutic genome editing.

Authors:  Matthew H Porteus
Journal:  Genome Biol       Date:  2015-12-22       Impact factor: 13.583

Review 8.  Spermatogonial stem cell autotransplantation and germline genomic editing: a future cure for spermatogenic failure and prevention of transmission of genomic diseases.

Authors:  Callista L Mulder; Yi Zheng; Sabrina Z Jan; Robert B Struijk; Sjoerd Repping; Geert Hamer; Ans M M van Pelt
Journal:  Hum Reprod Update       Date:  2016-05-30       Impact factor: 15.610

Review 9.  A Broad Overview and Review of CRISPR-Cas Technology and Stem Cells.

Authors:  Simon N Waddington; Riccardo Privolizzi; Rajvinder Karda; Helen C O'Neill
Journal:  Curr Stem Cell Rep       Date:  2016-02-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.